Matches in Ubergraph for { <https://frink.apps.renci.org/.well-known/genid/B896e12a89d65476c2bb328db5cddfe13> ?p ?o ?g. }
Showing items 1 to 5 of
5
with 100 items per page.
- B896e12a89d65476c2bb328db5cddfe13 NCIT_P378 "CDISC-GLOSS" @default.
- B896e12a89d65476c2bb328db5cddfe13 type Axiom @default.
- B896e12a89d65476c2bb328db5cddfe13 annotatedProperty NCIT_P325 @default.
- B896e12a89d65476c2bb328db5cddfe13 annotatedSource NCIT_C142444 @default.
- B896e12a89d65476c2bb328db5cddfe13 annotatedTarget "The act of concluding participation by an enrolled subject prior to completion of all protocol-required elements in a study. NOTE: Four categories of discontinuation are distinguished: a) dropout: Active discontinuation by a subject (also a noun referring to such a discontinued subject); b) investigator initiated discontinuation (e.g., for cause); c) loss to follow-up: cessation of participation without notice or action by the subject; d) sponsor initiated discontinuation. Note that subject discontinuation does not necessarily imply exclusion of subject data from analysis. "Termination of subject" has a history of synonymous use, but is now considered nonstandard. [After ICH E3, section 10.1 and FDA Guidance for Industry: Submission of Abbreviated Reports & Synopses in Support of Marketing Applications, IV A] See also withdrawal." @default.